UNITED THERAPEUTICS CORP.

In News

United Therapeutics (NASDAQ: UTHR) general counsel sells shares near $500 - Stock Titan

Stock Titan - Sep 18, 2026

United Therapeutics (UTHR) Sets $477.6 Million Buyback. Can Pipeline Funding Keep Pace? - Yahoo Finance

Yahoo Finance - Sep 10, 2026

United Therapeutics Insider Sold Shares Worth $4,712,580, According to a Recent SEC Filing - marketscreener.com

marketscreener.com - Sep 18, 2026

Director Nilda Mesa Sells 228 Shares of United Therapeutics Corp (UTHR) - GuruFocus

GuruFocus - Sep 16, 2026

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - ir.unither.com

ir.unither.com - Jan 21, 2026

United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors - Business Wire

Business Wire - Jul 23, 2026

United Therapeutics | UTHR Stock Price, Company Overview & News - forbes.com

forbes.com - Jun 24, 2026

Anheuser-Busch plant in Merrimack sold to United Therapeutics for $47.5M (copy) - UnionLeader.com

UnionLeader.com - Sep 15, 2026

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease - PR Newswire

PR Newswire - May 13, 2026

United Therapeutics (UTHR) CEO sells 9,500 shares under preset plan - Stock Titan

Stock Titan - Sep 18, 2026

Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation? - Yahoo Finance

Yahoo Finance - Jul 08, 2026

United Therapeutics (NASDAQ: UTHR) CEO exercises 9,500 options and sells matching shares - Stock Titan

Stock Titan - Sep 17, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment